These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10683014)

  • 41. Predictors of long-term HIV RNA suppression on darunavir/ritonavir monotherapy in the MONET trial.
    Arribas J; Pulido F; Hill A; Delft Yv; Moecklinghoff C
    Int J STD AIDS; 2013 Aug; 24(8):679-81. PubMed ID: 24014249
    [No Abstract]   [Full Text] [Related]  

  • 42. An unjustifiably alarming report of a fatal case of retroviral rebound syndrome.
    Angel-Moreno A; Perez-Arellano JL
    Clin Infect Dis; 2006 Mar; 42(5):732-3; author reply 733. PubMed ID: 16447127
    [No Abstract]   [Full Text] [Related]  

  • 43. HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy.
    Tamarit Mdel P; Quereda C; Gonzalez-Rozas M; Corral I; Casado JL
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):83-6. PubMed ID: 21504362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Preventing rebound viremia after ending ART. Long-term control].
    Bischoff A
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():10. PubMed ID: 25026845
    [No Abstract]   [Full Text] [Related]  

  • 45. Nevirapine toxicity--implications for management of South African patients.
    Wood R
    S Afr Med J; 2005 Apr; 95(4):253-7. PubMed ID: 15889848
    [No Abstract]   [Full Text] [Related]  

  • 46. HIV treatment decisions and transmitted drug resistance.
    Little SJ; Smith DM
    Clin Infect Dis; 2005 Jul; 41(2):233-5. PubMed ID: 15983921
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug-resistant genotyping in HIV-1 therapy.
    Nannini E
    Lancet; 1999 Sep; 354(9184):1121. PubMed ID: 10509523
    [No Abstract]   [Full Text] [Related]  

  • 48. Adherence to antiretroviral therapy: how much is enough?
    Gulick RM
    Clin Infect Dis; 2006 Oct; 43(7):942-4. PubMed ID: 16941381
    [No Abstract]   [Full Text] [Related]  

  • 49. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 50. The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection.
    ; Marcotullio S; Andreoni M; Antinori A; d'Arminio Monforte A; Di Perri G; Galli M; Ippolito G; Perno CF; Rizzardini G; Lazzarin A; ; Cinque P; Fares G; Foglia E; Gervasoni C; Murri R; Nozza S; Rusconi S
    New Microbiol; 2012 Jul; 35(3):259-77. PubMed ID: 22842596
    [No Abstract]   [Full Text] [Related]  

  • 51. [Integrase inhibition].
    Bogner JR
    MMW Fortschr Med; 2009 Apr; 151(18):68-71. PubMed ID: 19769082
    [No Abstract]   [Full Text] [Related]  

  • 52. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 53. [Saving on drugs, reducing side-effects. Treatment interruptions benefit acute and chronic HIV infected patients].
    Jäger H
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():8-11. PubMed ID: 12043085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
    Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
    J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lipodystrophy and metabolic disorders in anti-HIV therapy].
    Behrens GM; Stoll M; Schmidt RE
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():68-71. PubMed ID: 10863318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 57. Complications & side effects. Can statins be used as anti-HIV drugs?
    TreatmentUpdate; 2004; 16(7):9. PubMed ID: 17219689
    [No Abstract]   [Full Text] [Related]  

  • 58. Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection.
    Foster C; Fidler S
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1403-16. PubMed ID: 21133665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next?
    Cotton MF; Rabie H; van Zyl GU
    Clin Infect Dis; 2010 Mar; 50(6):909-11. PubMed ID: 20158399
    [No Abstract]   [Full Text] [Related]  

  • 60. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.